KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Divestments: 2017-2025

Historic Divestments for Bausch Health Companies (BHC) over the last 5 years, with Sep 2025 value amounting to $7.0 million.

  • Bausch Health Companies' Divestments rose 40.00% to $7.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.0 million, marking a year-over-year increase of 27.27%. This contributed to the annual value of $7.0 million for FY2024, which is 40.00% up from last year.
  • As of Q3 2025, Bausch Health Companies' Divestments stood at $7.0 million, which was up 40.00% from $5.0 million recorded in Q3 2024.
  • In the past 5 years, Bausch Health Companies' Divestments ranged from a high of $644.0 million in Q3 2021 and a low of $1.0 million during Q2 2023.
  • Over the past 3 years, Bausch Health Companies' median Divestments value was $2.5 million (recorded in 2023), while the average stood at $3.2 million.
  • Its Divestments has fluctuated over the past 5 years, first plummeted by 80.95% in 2021, then spiked by 40.00% in 2025.
  • Bausch Health Companies' Divestments (Quarterly) stood at $644.0 million in 2021, then reached $5.0 million in 2022, then reached $4.0 million in 2023, then grew by 25.00% to $5.0 million in 2024, then spiked by 40.00% to $7.0 million in 2025.
  • Its Divestments stands at $7.0 million for Q3 2025, versus $5.0 million for Q3 2024 and $1.0 million for Q2 2024.